Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of GBP 227.46 billion. The enterprise value is 254.23 billion.

Market Cap	227.46B
Enterprise Value	254.23B

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.98%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 16.77 and the forward PE ratio is 24.10.

PE Ratio	16.77
Forward PE	24.10
PS Ratio	4.71
PB Ratio	5.81
P/TBV Ratio	70.44
P/FCF Ratio	24.77
P/OCF Ratio	18.59
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.59, with an EV/FCF ratio of 27.68.

EV / Earnings	18.74
EV / Sales	5.26
EV / EBITDA	11.59
EV / EBIT	13.98
EV / FCF	27.68

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	7.15%
Revenue Per Employee	652,746
Profits Per Employee	183,280
Employee Count	75,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 2.08 billion in taxes.

Income Tax	2.08B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has decreased by -13.76% in the last 52 weeks. The beta is 0.67, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.67
52-Week Price Change	-13.76%
50-Day Moving Average	46.36
200-Day Moving Average	53.16
Relative Strength Index (RSI)	63.75
Average Volume (20 Days)	170,637

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.09

Income Statement

In the last 12 months, Merck & Co. had revenue of GBP 48.30 billion and earned 13.56 billion in profits. Earnings per share was 5.41.

Revenue	48.30B
Gross Profit	37.30B
Operating Income	18.18B
Pretax Income	15.65B
Net Income	13.56B
EBITDA	21.63B
EBIT	18.18B
Earnings Per Share (EPS)	5.41

Full Income Statement

Balance Sheet

The company has 10.82 billion in cash and 37.55 billion in debt, giving a net cash position of -26.72 billion.

Cash & Cash Equivalents	10.82B
Total Debt	37.55B
Net Cash	-26.72B
Net Cash Per Share	n/a
Equity (Book Value)	39.13B
Book Value Per Share	15.79
Working Capital	11.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 12.24 billion and capital expenditures -3.06 billion, giving a free cash flow of 9.18 billion.

Operating Cash Flow	12.24B
Capital Expenditures	-3.06B
Free Cash Flow	9.18B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

Merck & Co. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	1.34%
Earnings Yield	5.96%
FCF Yield	4.04%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5